Endovascular Treatment for Brain Blood Vessel Spasm After Aneurysm Rupture
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests an endovascular procedure (a minimally invasive catheter-based treatment delivered through blood vessels) combined with a heart medication called milrinone to treat cerebral vasospasm—dangerous blood vessel narrowing that can occur after a ruptured brain aneurysm. The goal is to improve neurological recovery and prevent stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You had a ruptured brain aneurysm confirmed by CT scan with the source identified by advanced imaging (CTA, MRA, or DSA)
- Your aneurysm was already treated with either endovascular coils or surgical clipping
- You have signs of cerebral vasospasm (blood vessel narrowing) within 14 days, shown by worsening neurological symptoms, ultrasound findings, or imaging
- You can tolerate a catheter-based procedure and do not have contraindications to milrinone (a heart medication)
- You do not have severe pre-existing brain or systemic diseases, poor blood pressure control, or are pregnant/breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a safe, non-invasive treatment called remote ischemic conditioning (using a blood pressure cuff on your leg) to see if it helps brain recovery after aneurysm surgery. It might reduce secondary damage and improve outcomes.
This trial studies a spinal fluid (CSF) treatment to help prevent dangerous blood-vessel tightening (vasospasm) after a type of brain bleed caused by an aneurysm. If you qualify, the goal is to reduce complications soon after aneurysm repair.
This study tests a treatment for people who have had a brain bleed (subarachnoid hemorrhage) and are at risk for delayed brain damage due to narrowed blood vessels. It looks at whether a special procedure to relax the vessels (spasmolysis) combined with raising blood pressure can prevent long-term harm.
This trial looks at a procedure that blocks specific nerves to help prevent or treat blood vessel spasm in the brain after a ruptured brain aneurysm. If you qualify, it may help improve blood flow to the brain during recovery in the ICU.
This trial tests whether a minimally invasive procedure to unblock blood vessels in the back of the brain (called endovascular treatment) can help patients whose stroke symptoms are getting worse between 1–2 weeks after the stroke started. The procedure aims to restore blood flow and prevent further brain damage.
This trial tests whether the drug cilostazol can prevent delayed brain damage in people who have had bleeding from a brain aneurysm. It is for adults who had their aneurysm treated within 72 hours and are in moderate to serious condition.
Hear when a new Subarachnoid Hemorrhage, Aneurysmal trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.